The Single-Cell Analysis Market size in the Middle East and Africa was valued at USD 0.18 billion in 2020 and estimated to be growing at a CAGR of 16.02% to reach USD 0.37 billion by 2025.
Increasing advancements in technology, growth in the biotechnology and biopharmaceutical industries, and extensive applications of single-cell analysis in cancer research are expected to propel the market growth in this region during the forecast period. Increasing funds and investments from the government and other organizations are likely to fuel the growth. Rising standard increases and a high occurrence rate of infectious and chronic diseases and neurological disorders foster the market. According to the Cancer Government, around 1.8 million people were diagnosed with cancer by the end of 2019, as of an increase in cancer as there is a considerable need for analysis of cancer cells, which surge the market growth throughout the review period. The government took increasing per capita income and steps to empower and strengthen the research and development activities towards the healthcare domain, which propels the market.
The expensive nature of the single-cell analysis products is to impede the market growth over the analysis period. Limited healthcare reimbursement policies and guidelines and also and affairs relevant to intellectual property hamper the market growth. Besides these, strict regulations for the approval of the new drug discovery and therapeutics and new products hinder the market. Massive competition in the market amidst already existing and the latest entries, which restrain the single-cell analysis market throughout the analysis period.
This research report on the Middle East & Africa Single Cell Analysis Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2025.
Regionally, Middle East & Africa is regarded to have a moderate tendency towards the growth of the single-cell analysis market during the region's assessment period. The increase is attributed due to the enhancement of advanced therapeutics for the treatment of cancer. UAE and South Africa are the two major contributors to the market in this region.
UAE is ruling this region's market during the period as of increasing attention towards personalized medicine and advancements in technologies for the single-cell analysis market, which fuels the market.
Following UAE in leading the market of this region as the factors causing the growth, South Africa is the introduction of new single-cell genomic centers for many years in projected to boost the market. Other countries like Saudi Arabia, Nigeria, Egypt, Ethiopia, and the rest of the MEA are expected to have notable growth in single-cell analysis during the assessment period.
Noteworthy Companies operating in the MEA Single-Cell Analysis Market Profiled in the Report are Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General ElectricCompany, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Cell
5.1.1 Introduction
5.1.2 Human Cells
5.1.3 Animal Cells
5.1.4 Microbial Cells
5.1.5 Y-o-Y Growth Analysis, By Cell
5.1.6 Market Attractiveness Analysis, By Cell
5.1.7 Market Share Analysis, By Cell
5.2 Products
5.2.1 Introduction
5.2.2 Consumables
5.2.3 Instruments
5.2.4 Y-o-Y Growth Analysis, By Products
5.2.5 Market Attractiveness Analysis, By Products
5.2.6 Market Share Analysis, By Products
5.3 Techniques
5.3.1 Introduction
5.3.2 Flow Cytometry
5.3.3 NGS
5.3.4 PCR
5.3.5 Microscopy
5.3.6 Mass Spectrometry
5.3.7 Other Techniquess
5.3.8 Y-o-Y Growth Analysis, By Techniques
5.3.9 Market Attractiveness Analysis, By Techniques
5.3.10 Market Share Analysis, By Techniques
5.4 Applications
5.4.1 Introduction
5.4.2 Research Application
5.4.3 Medical Application
5.4.4 Y-o-Y Growth Analysis, By Applications
5.4.5 Market Attractiveness Analysis, By Applications
5.4.6 Market Share Analysis, By Applications
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Cell
6.1.3.3 By Products
6.1.3.4 By Techniques
6.1.3.5 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Cell
6.1.4.3 By Products
6.1.4.4 By Techniques
6.1.4.5 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Cell
6.1.5.3 By Products
6.1.5.4 By Techniques
6.1.5.5 By Application
6.2 Middle-East
6.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five Analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Danaher Corporation
8.1.1 Overview
8.1.2 Cell Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck KGaA
8.3 Becton
8.4 Dickinson and Company
8.5 Promega Corporation
8.6 General Electric Company
8.7 Thermo Fisher Scientific
8.8 Miltenyi Biotec
8.9 Illumina
8.10 Bio-Rad Laboratories
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
